A Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769 (Casopitant).

Clinical trial NCT00405080 · COMPLETED

Trial details

NCT number: NCT00405080
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Nausea and Vomiting, Chemotherapy-Induced

Start date: 2006-11-11
Primary completion: 2007-01-05
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.